Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.09)
# 3,868
Out of 4,651 analysts
297
Total ratings
52.7%
Success rate
-0.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Rated: Hold | $1.75 → $1.5 | $1.85 | -18.92% | 27 | Aug 13, 2026 | |
| CTEV Claritev | Maintained: Hold | $22 → $30 | $38.12 | -21.30% | 4 | Aug 12, 2026 | |
| DOCS Doximity | Downgraded: Sell | $18 | $24.80 | -27.42% | 34 | Aug 10, 2026 | |
| AMWL American Well | Maintained: Buy | $16 | $12.45 | +28.51% | 18 | Aug 5, 2026 | |
| VEEV Veeva Systems | Maintained: Buy | $320 | $243.75 | +31.28% | 41 | Aug 2, 2026 | |
| OMCL Omnicell | Rated: Buy | $55 → $50 | $37.30 | +34.05% | 55 | Jul 30, 2026 | |
| TDOC Teladoc Health | Maintained: Hold | $6 | $6.81 | -11.89% | 9 | Jul 30, 2026 | |
| WAY Waystar Holding | Rated: Buy | $36 → $33 | $24.78 | +33.17% | 3 | Jul 30, 2026 | |
| HNGE Hinge Health | Rated: Buy | $80 → $90 | $88.49 | +1.71% | 5 | Jun 24, 2026 | |
| HQY HealthEquity | Rated: Buy | $125 | $104.73 | +19.35% | 55 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $3.73 | -6.17% | 35 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $12.28 | -26.71% | 6 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $18 | $24.04 | -25.12% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $16.34 | n/a | 1 | Oct 6, 2015 |
Health Catalyst
Aug 13, 2026
Rated: Hold
Price Target: $1.75 → $1.5
Current: $1.85
Upside: -18.92%
Claritev
Aug 12, 2026
Maintained: Hold
Price Target: $22 → $30
Current: $38.12
Upside: -21.30%
Doximity
Aug 10, 2026
Downgraded: Sell
Price Target: $18
Current: $24.80
Upside: -27.42%
American Well
Aug 5, 2026
Maintained: Buy
Price Target: $16
Current: $12.45
Upside: +28.51%
Veeva Systems
Aug 2, 2026
Maintained: Buy
Price Target: $320
Current: $243.75
Upside: +31.28%
Omnicell
Jul 30, 2026
Rated: Buy
Price Target: $55 → $50
Current: $37.30
Upside: +34.05%
Teladoc Health
Jul 30, 2026
Maintained: Hold
Price Target: $6
Current: $6.81
Upside: -11.89%
Waystar Holding
Jul 30, 2026
Rated: Buy
Price Target: $36 → $33
Current: $24.78
Upside: +33.17%
Hinge Health
Jun 24, 2026
Rated: Buy
Price Target: $80 → $90
Current: $88.49
Upside: +1.71%
HealthEquity
Jun 5, 2026
Rated: Buy
Price Target: $125
Current: $104.73
Upside: +19.35%
Jun 2, 2026
Maintained: Buy
Price Target: $3.5
Current: $3.73
Upside: -6.17%
May 28, 2026
Reiterated: Hold
Price Target: $9
Current: $12.28
Upside: -26.71%
May 8, 2026
Maintained: Hold
Price Target: $17 → $18
Current: $24.04
Upside: -25.12%
Oct 6, 2015
Initiated Coverage: Buy
Price Target: $34
Current: $16.34
Upside: n/a